Implementing a Methadone Delivery System in New York City in Response to Covid-19

Bibliographic Data

ID11035259
AuthorsAlex Harocopos (0000-0002-4650-762X, All authors are with the Bureau of Alcohol and Drug Use Prevention, Care, and Treatment, New York City Department of Health and Mental Hygiene, Queens, NY.), Michelle L Nolan (0000-0003-1951-4151, All authors are with the Bureau of Alcohol and Drug Use Prevention, Care, and Treatment, New York City Department of Health and Mental Hygiene, Queens, NY.), Gail P Goldstein (All authors are with the Bureau of Alcohol and Drug Use Prevention, Care, and Treatment, New York City Department of Health and Mental Hygiene, Queens, NY.), Shivani Mantha (0000-0003-2655-0206, All authors are with the Bureau of Alcohol and Drug Use Prevention, Care, and Treatment, New York City Department of Health and Mental Hygiene, Queens, NY.), Madeleine O’Neill (All authors are with the Bureau of Alcohol and Drug Use Prevention, Care, and Treatment, New York City Department of Health and Mental Hygiene, Queens, NY.), Denise Paone (All authors are with the Bureau of Alcohol and Drug Use Prevention, Care, and Treatment, New York City Department of Health and Mental Hygiene, Queens, NY.)
Year2021
Volume111
Issue12
Pages2115-2117
Publication date2021-12-01
Peer ReviewedYes
Open AccessNo
TypeARTICLE
VenueAmerican Journal of Public Health (JOURNAL)
Journal identifiersISSN: 0090-0036 • E-ISSN: 1541-0048
PublisherAmerican Public Health Association (PUBLISHER • US)
DOI10.2105/ajph.2021.306523
PMID34878865
OpenAlexW4200024166
LanguageEN
References cited5

Opioid agonist medication, including methadone, is considered the first-line treatment for opioid use disorder. Methadone, when taken daily, reduces the risk of fatal overdose; however, overdose risk increases following medication cessation. Amid an overdose epidemic accelerated by the proliferation of fentanyl, ensuring continuity of methadone treatment during the COVID-19 pandemic is a vital public health priority. (Am J Public Health. 2021;111(12):2115–2117. https://doi.org/10.2105/AJPH.2021.306523 )

(+)-Naloxone · 2019-20 coronavirus outbreak · Anesthesia · Buprenorphine · Coronavirus disease 2019 (COVID-19) · Disease · Drug overdose · Fentanyl · Infectious disease (medical specialty) · Methadone · Opiate Substitution Treatment · Opioid · Opioid overdose · Opioid use disorder · Pandemic · Poison control · Psychiatry · Public health · Emergency Medicine · Forensic Toxicology and Drug Analysis · Internal Medicine · Medicine · Nursing · Opioid Use Disorder Treatment · Pain Management and Opioid Use · Virology

Tools

Open DOIOpen Access